AI assistant
Sending…
ELI LILLY & Co — Director's Dealing 2014
Sep 3, 2014
29745_dirs_2014-09-03_b542bdc3-b69a-46aa-a8ab-1fc303f4b949.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2014-09-02
Reporting Person: Conterno Enrique A (Sr. VP & Pres., Lilly Diabetes)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-09-02 | Common Stock | S | 5000 | $63.60 | Disposed | 82736 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 4650 | Indirect |
Footnotes
F1: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 29, 2014.
More from ELI LILLY & Co
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 29